FI961435A0 - Transdermalt terapeutiskt system som innehåller oktyldodekanol som kristalliseringsinhibitorer - Google Patents

Transdermalt terapeutiskt system som innehåller oktyldodekanol som kristalliseringsinhibitorer

Info

Publication number
FI961435A0
FI961435A0 FI961435A FI961435A FI961435A0 FI 961435 A0 FI961435 A0 FI 961435A0 FI 961435 A FI961435 A FI 961435A FI 961435 A FI961435 A FI 961435A FI 961435 A0 FI961435 A0 FI 961435A0
Authority
FI
Finland
Prior art keywords
pct
octyldodecanol
system containing
therapeutic system
transdermal therapeutic
Prior art date
Application number
FI961435A
Other languages
English (en)
Finnish (fi)
Other versions
FI961435A (sv
Inventor
Guenter Cordes
Lucio C Rovati
Original Assignee
Rotta Research Lab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Rotta Research Lab filed Critical Rotta Research Lab
Publication of FI961435A publication Critical patent/FI961435A/sv
Publication of FI961435A0 publication Critical patent/FI961435A0/sv

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
    • A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
    • A61K9/7053—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained by reactions only involving carbon to carbon unsaturated bonds, e.g. polyvinyl, polyisobutylene, polystyrene
    • A61K9/7061—Polyacrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone

Landscapes

  • Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Chemical & Material Sciences (AREA)
  • Dermatology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
FI961435A 1993-10-01 1996-03-29 Transdermalt terapeutiskt system som innehåller oktyldodekanol som kristalliseringsinhibitorer FI961435A0 (sv)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE4333595A DE4333595A1 (de) 1993-10-01 1993-10-01 Transdermales therapeutisches System zur Applikation von Arzneimitteln auf die Haut
PCT/EP1994/003269 WO1995009618A1 (de) 1993-10-01 1994-09-30 Transdermales therapeutisches system enthaltend octyldodecanol als kristallisationsinhibitor

Publications (2)

Publication Number Publication Date
FI961435A FI961435A (sv) 1996-03-29
FI961435A0 true FI961435A0 (sv) 1996-03-29

Family

ID=6499233

Family Applications (1)

Application Number Title Priority Date Filing Date
FI961435A FI961435A0 (sv) 1993-10-01 1996-03-29 Transdermalt terapeutiskt system som innehåller oktyldodekanol som kristalliseringsinhibitorer

Country Status (12)

Country Link
US (1) US5711962A (sv)
EP (1) EP0721334B1 (sv)
JP (1) JPH09503217A (sv)
AT (1) ATE175346T1 (sv)
AU (1) AU680050B2 (sv)
CA (1) CA2172738A1 (sv)
DE (2) DE4333595A1 (sv)
DK (1) DK0721334T3 (sv)
ES (1) ES2130446T3 (sv)
FI (1) FI961435A0 (sv)
GR (1) GR3029392T3 (sv)
WO (1) WO1995009618A1 (sv)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU559553B2 (en) * 1981-09-11 1987-03-12 Dayco Products, Inc. Belt tensioner, part therefor, and methods of making the same
US5252334A (en) * 1989-09-08 1993-10-12 Cygnus Therapeutic Systems Solid matrix system for transdermal drug delivery
RU2177311C2 (ru) * 1995-06-07 2001-12-27 Орто-Макнейл Фармасьютикалз Инк. Трансдермальный пластырь для введения 17-деацетилноргестимата отдельно или в сочетании с эстрогеном
DE19526864A1 (de) * 1995-07-22 1997-01-23 Labtec Gmbh Hormonpflaster
DE19548332A1 (de) * 1995-12-22 1997-07-10 Rotta Res Bv Hormonpflaster
DE19700913C2 (de) * 1997-01-14 2001-01-04 Lohmann Therapie Syst Lts Transdermales therapeutisches System zur Abgabe von Hormonen
DE19738855C2 (de) * 1997-09-05 2001-01-04 Lohmann Therapie Syst Lts Transdermales therapeutisches System mit haftklebender Reservoirschicht und unidirektional elastischer Rückschicht
DE19827732A1 (de) * 1998-06-22 1999-12-23 Rottapharm Bv Transdermales System vom Matrix-Typ zur Abgabe von Wirkstoffen mit einer hohen Abgaberate von Steroid-Hormonen und die Verwendung eines derartigen Systems zur Hormonersatztherapie
DE19828273B4 (de) * 1998-06-25 2005-02-24 Lts Lohmann Therapie-Systeme Ag Transdermales therapeutisches System, enthaltend Hormone und Kristallisationsinhibitoren
DE19828274C2 (de) * 1998-06-25 2002-11-28 Rottapharm Bv Transdermales therapeutisches System, enthaltend Hormone und Kristallisationsinhibitoren
US7025979B2 (en) 2000-02-15 2006-04-11 Schering Ag Male contraceptive formulation comprising norethisterone
US20060142257A1 (en) * 2001-01-19 2006-06-29 Eberhard Nieschlag Male contraceptive formulation comprising norethisterone
GB2373421B (en) * 2001-03-16 2004-04-14 Cambridge Broadband Ltd Wireless communication system
WO2002102390A1 (en) 2001-06-18 2002-12-27 Noven Pharmaceuticals, Inc. Enhanced drug delivery in transdermal systems
US8124122B2 (en) 2002-08-09 2012-02-28 Teikoku Seiyaku Co., Ltd. Female hormone-containing patch
JP4824963B2 (ja) 2004-08-12 2011-11-30 日東電工株式会社 貼付材及び貼付製剤
JP4745747B2 (ja) 2004-08-12 2011-08-10 日東電工株式会社 フェンタニル含有貼付製剤
JP5547065B2 (ja) * 2008-05-15 2014-07-09 久光製薬株式会社 パロノセトロンを含有する経皮吸収製剤

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2902414A1 (de) * 1979-01-23 1980-08-07 Hoechst Ag Depotkoerper auf basis silicon- kautschuk sowie verfahren zu seiner herstellung
ATE23356T1 (de) * 1980-06-05 1986-11-15 Smith & Mclaurin Verfahren zur herstellung eines wasseraktivierbaren, klebenden beschichtungsmaterials auf der basis von staerke.
DE3634016A1 (de) * 1986-04-17 1987-10-29 Lohmann Gmbh & Co Kg Flaechenfoermiges therapeutisches system, verfahren zu seiner herstellung und seine verwendung
FR2612785A1 (fr) * 1987-03-25 1988-09-30 Lhd Lab Hygiene Dietetique Dispositif auto-adhesif d'administration d'un principe actif par voie percutanee
CH674618A5 (sv) * 1987-04-02 1990-06-29 Ciba Geigy Ag
JPH0745062B2 (ja) * 1987-10-30 1995-05-17 川崎重工業株式会社 二重管製造方法
AU644815B2 (en) * 1989-09-08 1993-12-23 Ortho-Mcneil Pharmaceutical, Inc. Solid matrix system for transdermal drug delivery
DE3933460A1 (de) * 1989-10-06 1991-04-18 Lohmann Therapie Syst Lts Oestrogenhaltiges wirkstoffpflaster
DE3942232A1 (de) * 1989-12-21 1991-06-27 Beiersdorf Ag Schmelzhaftkleber auf acrylatbasis
DE4020144A1 (de) * 1990-06-25 1992-01-09 Lohmann Therapie Syst Lts Pflaster mit hohem gehalt an weichmachenden inhaltsstoffen
US5198223A (en) * 1990-10-29 1993-03-30 Alza Corporation Transdermal formulations, methods and devices
DE4210711A1 (de) * 1991-10-31 1993-05-06 Schering Ag Berlin Und Bergkamen, 1000 Berlin, De Transdermale therapeutische systeme mit kristallisationsinhibitoren
IT1253265B (it) * 1991-11-25 1995-07-14 Rotta Research Lab Preparato a matrice copolimerica adesiva a base acrilica per il rilascio transdermico dell'estradiolo.

Also Published As

Publication number Publication date
DK0721334T3 (da) 1999-08-30
EP0721334B1 (de) 1999-01-07
DE59407605D1 (de) 1999-02-18
JPH09503217A (ja) 1997-03-31
WO1995009618A1 (de) 1995-04-13
US5711962A (en) 1998-01-27
EP0721334A1 (de) 1996-07-17
AU7784494A (en) 1995-05-01
ATE175346T1 (de) 1999-01-15
FI961435A (sv) 1996-03-29
GR3029392T3 (en) 1999-05-28
ES2130446T3 (es) 1999-07-01
AU680050B2 (en) 1997-07-17
DE4333595A1 (de) 1995-04-06
CA2172738A1 (en) 1995-04-13

Similar Documents

Publication Publication Date Title
FI961435A0 (sv) Transdermalt terapeutiskt system som innehåller oktyldodekanol som kristalliseringsinhibitorer
DK0744944T3 (da) Transdermale terapeutiske systemer indeholdende kønssterioder
NO308794B1 (no) Farmakologisk aktive pyridin-derivater, preparater inneholdende forbindelsene samt forbindelsenes anvendelse
DE69408666D1 (de) Risperidon pamoate
CA2034934A1 (en) Transdermal Therapeutic System Comprising Tulobuterol as Active Substance
MY114388A (en) Multiple unit pharmaceutical preparation
DE122005000055I1 (de) Kristallines ceftiofur (freie S{ure)
FI952900A0 (sv) Polypeptid och därav framställt anti-HIV-ämne
DK0719154T3 (da) Aktiveret faktor VIII som terapeutisk middel og metode til behandling af faktor VIII-mangel
ES2012580A6 (es) Procedimiento para la produccion de una nueva forma cristalina de ciclosporinas.
FI961282A (sv) Transdermalt terapeutiskt system med acetylsalicylsyra som verksamt ämne
DK0710108T3 (da) Flydende, farmaceutisk præparat til oral anvendelse indeholdende 2-(4-isobutylphenyl)-propionsyre
ATE152628T1 (de) Verwendung von parathormone, seinen biologisch aktiven fragmenten oder von verwandten peptiden zur behandlung von schwangerschaft
FI962550A0 (sv) Deuteriserade aktiva substanser i transdermal användning
AU6087194A (en) Hiv protease inhibitors
IL111917A0 (en) A pharmaceutical composition containing a parasympathomimetic compound and a parasympatholytic compound
DK0742716T3 (da) Farmaceutisk sammensætning til systemisk transdermal indgivelse med det aktive middel morphin-6-glucuronid
DE69623641T2 (de) Topisch anzuwendendes abschäumendes arzneimittel zur behandlung von durch pityrosporum ovale verursachten hauterkrankungen
ATE169819T1 (de) (-)-metrifonat enthaltendes arzneimittel
CA2251353A1 (en) Transdermal delivery device for azapirone compounds
ES2156938T3 (es) Forma de presentacion transdermica de nitroglicerina para impedir una indeseada actividad de contracciones del parto.